SCHEMBL10274263

SCHEMBL10274263

COCCOCCOCCOCCOCCOCCOCCN(C)C(=O)[C@@H]1CCCN1CCN(C)C(=O)c1cccc(C(=O)Nc2ccc(N3CCCCC3)cc2-c2cc(C(N)=O)ccn2)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 2/20 0.33
SLC34A2 O95436 1/20 0.33
TP53BP1 Q12888 2/20 0.32
CARM1 Q86X55 1/20 0.32
EPHX2 P34913 1/20 0.32
DRD4 P21917 1/20 0.32
MAP4K1 Q92918 1/20 0.32
KCNH2 Q12809 1/20 0.32
ROCK2 O75116 1/20 0.31
MAPK14 Q16539 1/20 0.31
ATR Q13535 1/20 0.31
IGF1R P08069 1/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
HDAC1 Q13547 1/20 0.31
SIRT2 Q8IXJ6 1/20 0.31
SIRT1 Q96EB6 1/20 0.31
SIRT3 Q9NTG7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18482346 0.95 SLC34A2 (0.38) IRAK4SLC34A2TP53BP1EPHX2KCNH2
SCHEMBL19596002 0.94 IRAK4 (0.32) IRAK4SLC34A2TP53BP1EPHX2KCNH2
SCHEMBL10274107 0.92 SLC34A2 (0.34) IRAK4SLC34A2TP53BP1CARM1EPHX2
SCHEMBL15432836 0.88 CTSS (0.37) MEN1KMT2AALDH1A1LMNAPKM
SCHEMBL15420656 0.88 CTSS (0.37) MEN1KMT2AALDH1A1LMNAPKM
SCHEMBL18482731 0.87 SLC34A2 (0.39) IRAK4SLC34A2TP53BP1EPHX2KCNH2
SCHEMBL10274775 0.84 SLC34A2 (0.34) SLC34A2TP53BP1EPHX2
SCHEMBL15432828 0.84 CTSS (0.37) SLC34A2MEN1KMT2AALDH1A1LMNA
SCHEMBL6001372 0.84 CTSS (0.37) SLC34A2MEN1KMT2AALDH1A1LMNA
SCHEMBL18059184 0.83 SLC34A2 (0.35) SLC34A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170037010-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. 2017-02-09 US disclosed
WO-2012006475-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. (US) 2012-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170037010-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT SLC34A2, SLC34A1, SLC10A2 IRAK4 4860/4885SLC34A2 1/4885TP53BP1 3967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.